{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:05:03Z","timestamp":1790661903893,"version":"4.1.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite effective viral suppression with antiretroviral therapy (ART), people living with HIV (PLWH) often experience persistent immune activation and incomplete immune reconstitution. Gut barrier disruption and gut microbial dysbiosis contribute to chronic inflammation in PLWH. Shen Ling Ai Cao pill (SLAC) may have immunomodulatory effects, however, changes in the gut microbiota and fecal metabolome during SLAC administration remain unclear. This study aimed to characterize changes in the gut microbiota and fecal metabolome during SLAC administration in PLWH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single-arm study, 46 PLWH on long-term ART received adjunctive SLAC for 6 months. Fecal samples were collected, and peripheral CD4+ and CD8+ T-cell counts and the CD4\/CD8 ratio were measured at baseline and month 6. Gut microbiota were profiled by 16S rRNA gene sequencing, and untargeted metabolomics was performed to characterize fecal metabolic changes. Microbial diversity, differential taxa, functional pathways, differential metabolites, and KEGG enrichment were analyzed. Correlation analyses were conducted to explore associations among gut microbiota, metabolites, and T-cell subsets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 46 PLWH enrolled, 42 completed the 6-month follow-up and were included in the final analysis. From M0 to M6, median CD8+ T-cell counts increased from 448.5 to 565.0 cells\/mm\n                      <jats:sup>3<\/jats:sup>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.047), whereas median CD4+ T-cell counts increased non-significantly from 308.0 to 330.0 cells\/mm\n                      <jats:sup>3<\/jats:sup>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.118), with no change in the CD4\/CD8 ratio (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.89). Differences were also observed in gut microbial composition and fecal metabolomic profiles. Correlation analyses identified associations between gut microbial taxa and CD4+ and CD8+ T-cell counts. A total of 59 differential metabolites were identified, and enrichment analysis implicated lipid metabolism, bile acid metabolism, cholesterol metabolism, and mTOR signaling.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this single-arm longitudinal study of ART-treated PLWH, 6 months of adjunctive SLAC administration was associated with changes in fecal microbial composition, fecal metabolomic profiles, and CD8+ T cell counts, whereas CD4+ T cell counts showed a nonsignificant increasing trend. Controlled studies are needed to determine whether these changes are attributable to SLAC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmicb.2026.1920281","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:47:40Z","timestamp":1790660860000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The gut microbiome and metabolome of people living with HIV altered during treatment"],"prefix":"10.3389","volume":"17","author":[{"given":"Xue","family":"Ding","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahe","family":"Li","sequence":"additional","affiliation":[{"name":"Tianjin University of Chinese Medicine","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyu","family":"Qian","sequence":"additional","affiliation":[{"name":"Henan University of Chinese Medicine","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Yue","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxia","family":"Ma","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liran","family":"Xu","sequence":"additional","affiliation":[{"name":"Henan University of Chinese Medicine","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/OLQ.0000000000001366","article-title":"Estimated lifetime HIV-related medical costs in the United States","volume":"48","author":"Bingham","year":"2021","journal-title":"Sex. Transm. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1084\/jem.20151159","article-title":"T cell metabolism drives immunity","volume":"212","author":"Buck","year":"2015","journal-title":"J. Exp. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"107654","DOI":"10.1016\/j.phrs.2025.107654","article-title":"Gut microbiome-derived indole-3-carboxaldehyde regulates stress vulnerability in chronic restraint stress by activating aryl hydrocarbon receptors","volume":"213","author":"Chen","year":"2025","journal-title":"Pharmacol Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2480645","DOI":"10.1080\/17441692.2025.2480645","article-title":"Attitudes and behaviours associated with HIV transmission in men who have sex with men in Portugal - a qualitative study","volume":"20","author":"Correia","year":"2025","journal-title":"Glob. Public Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/QAD.0000000000001366","article-title":"Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation","volume":"31","author":"Dillon","year":"2017","journal-title":"Aids"},{"key":"B7","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/mi.2013.116","article-title":"An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia","volume":"7","author":"Dillon","year":"2014","journal-title":"Mucosal Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.2147\/IDR.S526449","article-title":"Clinical applications and therapeutic mechanisms of Chinese herbal medicine Yiaikang capsules in treating acquired immune deficiency syndrome","volume":"18","author":"Ding","year":"2025","journal-title":"Infect. Drug Resist."},{"key":"B9","doi-asserted-by":"publisher","first-page":"121641","DOI":"10.1016\/j.jep.2026.121641","article-title":"Efficacy and safety of the Chinese herbal medicine Yiaikang capsule in treating AIDS: a randomized, double-blind, controlled trial","volume":"367","author":"Ding","year":"2026","journal-title":"J. Ethnopharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/infdis\/jiu409","article-title":"Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection","volume":"211","author":"Dinh","year":"2015","journal-title":"J. Infect. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.micpath.2008.09.004","article-title":"Escherichia albertii and Hafnia alvei are candidate enteric pathogens with divergent effects on intercellular tight junctions","volume":"45","author":"Donato","year":"2008","journal-title":"Microb. Pathog."},{"key":"B12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s12866-020-02023-y","article-title":"Indole-3-lactic acid associated with Bifidobacterium-dominated microbiota significantly decreases inflammation in intestinal epithelial cells","volume":"20","author":"Ehrlich","year":"2020","journal-title":"BMC Microbiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/imr.12823","article-title":"T-cell exhaustion in HIV infection","volume":"292","author":"Fenwick","year":"2019","journal-title":"Immunol Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.immuni.2021.06.007","article-title":"Transforming growth factor-\u03b2-regulated mTOR activity preserves cellular metabolism to maintain long-term T cell responses in chronic infection","volume":"54","author":"Gabriel","year":"2021","journal-title":"Immunity"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2393270","DOI":"10.1080\/19490976.2024.2393270","article-title":"The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease","volume":"16","author":"Hays","year":"2024","journal-title":"Gut Microbes"},{"key":"B16","first-page":"15","article-title":"Observation of the therapeutic effects of traditional Chinese medicine and correlation analysis in HIV-infected patients with deficiency constitution during the asymptomatic stage","volume":"40","author":"Lan","year":"2024","journal-title":"Pharmacol. Clinics Chin. Mater. Med"},{"key":"B17","first-page":"92","article-title":"Exploring the mechanism of action of Jian'aikang concentrated pills in the treatment of AIDS based on network pharmacology and experimental validation","volume":"43","author":"Lan","year":"2025","journal-title":"Sichuan J. Tradit. Chin. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/B978-0-12-407707-2.00002-3","article-title":"Residual immune dysregulation syndrome in treated HIV infection","volume":"119","author":"Lederman","year":"2013","journal-title":"Adv. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1698434","DOI":"10.3389\/fphar.2025.1698434","article-title":"Traditional Chinese medicine for HIV-related chronic comorbidities: evidence and potential therapeutic mechanisms","volume":"16","author":"Li","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B20","first-page":"431","article-title":"Research progress on the prevention and treatment of AIDS with the Fuzheng approach in traditional Chinese medicine from the perspective of T-cell exhaustion","volume":"30","author":"Li","year":"2024","journal-title":"Chin. J. AIDS STD"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/s41401-021-00781-7","article-title":"Baicalein ameliorates ulcerative colitis by improving intestinal epithelial barrier via AhR\/IL-22 pathway in ILC3s","volume":"43","author":"Li","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"B22","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1586\/14787210.2015.1029917","article-title":"Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review","volume":"13","author":"Manzardo","year":"2015","journal-title":"Expert Rev Anti Infect Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3390\/biomedicines11010159","article-title":"The many faces of immune activation in HIV-1 infection: a multifactorial interconnection","volume":"11","author":"Mazzuti","year":"2023","journal-title":"Biomedicines"},{"key":"B24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40168-019-0687-5","article-title":"Evolution of the gut microbiome following acute HIV-1 infection","volume":"7","author":"Rocafort","year":"2019","journal-title":"Microbiome"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.2147\/DDDT.S369832","article-title":"Study on the mechanism of improving HIV\/AIDS immune function with Jian Aikang concentrated pill based on network pharmacology combined with experimental validation","volume":"16","author":"Shao","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"100340","DOI":"10.1016\/j.crmicr.2025.100340","article-title":"Interrelationship between altered metabolites and the gut microbiota in people living with HIV with different immune responses to antiretroviral therapy","volume":"8","author":"Tian","year":"2025","journal-title":"Curr. Res. Microb. Sci"},{"key":"B27","first-page":"354","article-title":"Effects of Jian'aikang concentrated pills in combination with cART on intestinal function and gut microbiota in HIV-infected patients","volume":"30","author":"Yang","year":"2024","journal-title":"Chin. J. AIDS STD"},{"key":"B28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/COH.0000000000000234","article-title":"Microbial translocation and microbiome dysbiosis in HIV-associated immune activation","volume":"11","author":"Zevin","year":"2016","journal-title":"Curr. Opin. HIV AIDS"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1920281\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:47:42Z","timestamp":1790660862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1920281\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":28,"alternative-id":["10.3389\/fmicb.2026.1920281"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1920281","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"article-number":"1920281"}}